Nature Reviews Cardiology

Papers
(The H4-Index of Nature Reviews Cardiology is 71. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives964
Myocardial ischaemia–reperfusion injury and cardioprotection in perspective620
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions615
Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension581
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control406
Interplay between inflammation and thrombosis in cardiovascular pathology398
Smart wearable devices in cardiovascular care: where we are and how to move forward357
Artificial intelligence-enhanced electrocardiography in cardiovascular disease management355
PPAR control of metabolism and cardiovascular functions347
Global epidemiology of dyslipidaemias334
The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease315
Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases311
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation292
Epidemiology of cardiovascular disease in Europe286
Pathophysiology of sepsis-induced cardiomyopathy273
Global epidemiology of valvular heart disease257
Transportation noise pollution and cardiovascular disease235
Self-powered cardiovascular electronic devices and systems212
Cellular and molecular pathobiology of heart failure with preserved ejection fraction208
Epicardial adipose tissue in contemporary cardiology207
Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6207
Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis206
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium191
Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes183
Cardiovascular disease in patients with severe mental illness180
Ceramides and other sphingolipids as drivers of cardiovascular disease177
The role of cardiac rehabilitation in improving cardiovascular outcomes173
Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms170
Heart failure with mid-range or mildly reduced ejection fraction169
Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging154
Systems biology in cardiovascular disease: a multiomics approach150
Optical coherence tomography in coronary atherosclerosis assessment and intervention146
Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?146
Lifestyle interventions for the prevention and treatment of hypertension142
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches142
Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity139
Epidemiology of the inherited cardiomyopathies134
Sit less and move more for cardiovascular health: emerging insights and opportunities134
Integration of novel monitoring devices with machine learning technology for scalable cardiovascular management124
The quiescent endothelium: signalling pathways regulating organ-specific endothelial normalcy124
Genomics of hypertension: the road to precision medicine112
Transforming growth factor-β in myocardial disease109
High-density lipoproteins, reverse cholesterol transport and atherogenesis105
Genomic frontiers in congenital heart disease104
Blood pressure and its variability: classic and novel measurement techniques103
Cardiac optogenetics: a decade of enlightenment101
The role of cellular senescence in cardiac disease: basic biology and clinical relevance101
Apolipoproteins in vascular biology and atherosclerotic disease100
Vascular endothelial cell development and diversity99
Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease98
Catheter ablation for atrial fibrillation: current indications and evolving technologies98
Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development97
Mechanisms and consequences of endothelial cell senescence96
Applications of artificial intelligence in cardiovascular imaging89
Cardiovascular risks of climate change86
Complete versus incomplete coronary revascularization: definitions, assessment and outcomes84
Climate change and cardiovascular disease: implications for global health83
The role of mitochondrial fission in cardiovascular health and disease82
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action82
Epidemiology and prevention of venous thromboembolism81
RNA-targeting and gene editing therapies for transthyretin amyloidosis80
Update on the pathophysiology and medical treatment of peripheral artery disease80
Cardiac involvement in the long-term implications of COVID-1979
Sulfide regulation of cardiovascular function in health and disease77
Obesity and the risk of cardiometabolic diseases75
Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology74
Myocardial stunning and hibernation revisited74
Epidemiology and modifiable risk factors for atrial fibrillation74
Bleeding avoidance strategies in percutaneous coronary intervention74
Branched-chain amino acids in cardiovascular disease73
Clinical utility of polygenic risk scores for coronary artery disease71
0.054931163787842